Summary of findings 2. Pre and post operative medical therapies versus placebo for endometriosis.
| Pre and post operative medical therapies versus placebo for endometriosis | ||||||
| Patient or population: patients with infertility associated with endometriosis Intervention: Post surgical medical therapies Comparison: Pre and post‐surgical medical therapy with GnRHa | ||||||
| Outcomes | Illustrative comparative risks* (95% CI) | Relative effect (95% CI) | No of Participants (studies) | Quality of the evidence (GRADE) | Comments | |
| Assumed risk | Corresponding risk | |||||
| Pre and post‐surgical medical therapy with GnRHa | Post surgical medical therapies | |||||
| Pregnancy Rate | 500 per 1000 | 0 per 1000 (0 to 0) | RR 0 (0 to 0) | 25 (1 study) | ⊕⊕⊝⊝ low1 | |
| *The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI). CI: Confidence interval; RR: Risk ratio; | ||||||
| GRADE Working Group grades of evidence High quality: Further research is very unlikely to change our confidence in the estimate of effect. Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. Very low quality: We are very uncertain about the estimate. | ||||||
1 Description of randomisation , allocation concealment and blinding not adequate.